Core Scientific, Inc. Stock Prediction and Forecast [CORZ]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 09 Sept 2025, 03:24 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for Core Scientific, Inc. Stock Prediction and Forecast [CORZ]](https://i.ytimg.com/vi/obpz9o8bSuA/hqdefault.jpg)
AI-generated source summary
The video provides a stock analysis for Core Scientific (CORZ), beginning September 8th, 2025, with CORZ being ranked as a buy candidate. The analysis notes CORZ resides in the lower range of a weak upward trend, potentially offering a buying opportunity. A breach of $13.06 could signify a slower increase, or potential trend shift. The stock's three-month trend indicates a 4.79% change ranging from -1.77% to +40.05%. In the longer term (12 months) a projected change is -6.64% which can fluctuate from -60.44% to 19.11%, it could be between $5.51 and $16.59. The last trading day on September 8th, 2025 saw a 2.28% increase from $13.62 to $13.93, fluctuating by 3.53% between $13.60 and $14.08, with volume falling by 3 million shares to 7 million at $91.65M. Core Scientific faces scrutiny related to its proposed $9B all-stock sale to CoreWeave, with shareholder law firms opening investigations and total revenue declining 44% with $0.04 loss per share besting expectations. Analysts rated CORZ neutral (Roth Capital) with a hold, buy (Jeffries) with a hold, downgraded (Citigroup) and sell (Guggenheim) rating. Trading levels suggest a stop-loss at $13.41 is advisable, given the observed medium volatility and risk for the stock.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.